SCHEMBL2642878

SCHEMBL2642878

CCS(=O)(=O)c1cccc(Cl)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.43
ACLY P53396 2/20 0.40
COMT P21964 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
HSD11B1 P28845 2/20 0.39
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 2/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
ATM Q13315 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2643715 0.80 MCOLN3 (0.50) CXCR2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2642805 0.80 HSD11B1 (0.42) ACLYHSD11B1ALDH1A1MEN1KMT2A
SCHEMBL8765900 0.79 PSIP1 (0.48) HSD11B1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL9540649 0.79 ACLY (0.43) ACLYHSD11B1ALDH1A1MEN1KMT2A
SCHEMBL29707954 0.79 PSIP1 (0.48) HSD11B1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2642877 0.78 PSIP1 (0.39) CXCR2HSD11B1ALDH1A1CYP1A2CYP3A4
SCHEMBL10423502 0.78 TTR (0.42) ACLYHSD11B1ALDH1A1CYP1A2MEN1
SCHEMBL27812266 0.78 ACLY (0.42) ACLYHSD11B1ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL27286541 0.76 ACLY (0.41) ACLYHSD11B1ALDH1A1CYP1A2CYP3A4
SCHEMBL6657862 0.76 CA1 (0.55) ACLYALDH1A1MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687502-B2 Substituted quinazoline or pyridopyrimidine derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-30 US disclosed
US-20080032996-A1 Substituted Quinazoline or Pyridopyrimidine Derivative MSD K.K. (JP) 2008-02-07 US disclosed
EP-1734040-A1 SUBSTITUTED QUINAZOLINE OR PYRIDOPYRIMIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032996-A1 Substituted Quinazoline or Pyridopyrimidine Derivative GCK, GCKR, PDXK CXCR2 1500/4885ACLY 904/4885COMT 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.